Nocturnal Vomiting: Consider Cyclic Vomiting Syndrome
When vomiting occurs predominantly at night in a patient with normal endoscopy and CT enterography, cyclic vomiting syndrome (CVS) should be strongly considered, and prophylactic therapy should be initiated rather than pursuing repeated imaging studies.
Key Diagnostic Considerations
Nocturnal vomiting with negative structural workup is a red flag for CVS, particularly when episodes are stereotypical and recurrent. The 2024 AGA guidelines explicitly state that repeated esophagogastroduodenoscopy or upper gastrointestinal imaging studies should be avoided once obstructive lesions have been excluded 1. Your patient has already had appropriate one-time structural evaluation.
Important CVS Features to Assess:
- Episodic pattern: Discrete episodes separated by symptom-free intervals
- Stereotypical nature: Each episode follows similar pattern in timing, duration, and severity
- Nocturnal predominance: Many CVS patients experience symptoms at night or early morning
- Associated symptoms: Headache, photophobia, or abdominal pain during episodes
- Triggers: Stress, sleep deprivation, infections, or specific foods
Cannabis Use Assessment
Before finalizing CVS diagnosis, evaluate cannabis use patterns carefully. The guidelines distinguish CVS from cannabinoid hyperemesis syndrome (CHS) based on:
- Timing: Cannabis use that predates symptom onset by >1 year suggests CHS
- Frequency: Heavy use (>4 times weekly, often daily) points toward CHS
- Diagnostic test: 6 months cannabis cessation or at least 3 typical cycle lengths; continued vomiting after this rules out CHS 1
Critical point: Even with ongoing cannabis use, patients deserve treatment trials as these can still be effective 1.
Prophylactic Treatment Strategy
For nocturnal vomiting consistent with CVS, prophylactic therapy is the cornerstone of management, not abortive therapy alone. The 2024 AGA guidelines recommend:
First-Line Prophylactic Options:
Tricyclic antidepressants (amitriptyline 25-100 mg at bedtime, nortriptyline 25-100 mg at bedtime)
- Most evidence-supported for CVS prophylaxis
- Nocturnal dosing addresses nighttime symptoms
- Baseline ECG required due to QTc prolongation risk 1
Levetiracetam (alternative if TCAs contraindicated)
- Particularly useful for patients with migraine features
Abortive Therapy for Breakthrough Episodes:
If episodes occur despite prophylaxis:
- Ondansetron 4-8 mg (5-HT3 antagonist) 1, 2
- Promethazine 12.5-25 mg every 4-6 hours 1
- Lorazepam 0.5-2 mg for sedation and anxiety component 1
What NOT to Do
Common pitfalls to avoid:
- Ordering gastric emptying studies (rarely helpful in CVS and uninterpretable during episodes) 1
- Repeated endoscopy or imaging (yields no additional information)
- Attributing mild gastritis or erythematous streaking seen on endoscopy as causal (these are epiphenomena of recent vomiting) 1
- Withholding treatment while awaiting cannabis cessation results
Multidisciplinary Referrals
Consider involving:
- Neurology: If headache is prominent or any localizing neurologic symptoms exist 1
- Sleep specialist: Nocturnal symptoms may relate to sleep disorders
- Psychiatry/psychology: CVS has strong stress and anxiety associations 1
Monitoring and Follow-up
Track episode frequency, duration, and severity to assess prophylactic therapy effectiveness. Adjust medications based on response over 4-8 weeks. The goal is reducing episode frequency and severity, not necessarily complete elimination.